These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function. Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434 [TBL] [Abstract][Full Text] [Related]
7. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants. Cecka JM Clin Transpl; 1997; ():1-14. PubMed ID: 9919387 [TBL] [Abstract][Full Text] [Related]
8. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients. Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446 [No Abstract] [Full Text] [Related]
9. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Halloran PF; Aprile MA; Farewell V; Ludwin D; Smith EK; Tsai SY; Bear RA; Cole EH; Fenton SS; Cattran DC Transplantation; 1988 Aug; 46(2):223-8. PubMed ID: 3043779 [TBL] [Abstract][Full Text] [Related]
10. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation. Taylor HE; Ackman CF; Horowitz I Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705 [TBL] [Abstract][Full Text] [Related]
11. A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group. MacDonald AS; Daloze P; Dandavino R; Jindal S; Bear L; Dossetor JB; Klassen J; Stiller CR; Lockwood B; Reeve CE Transplant Proc; 1987 Feb; 19(1 Pt 3):1865-6. PubMed ID: 3079054 [TBL] [Abstract][Full Text] [Related]